It’s been 2 months since the listing and IPO.
The first few months in the life of a drug development company is all about laying foundations. Everyone is looking for news flow as evidence of activity, but that requires first building the platforms that will deliver the news flow. As the platforms are progressively built, so the news flow will follow.
Clinical activity
The focus has been on bringing NOX66 into the clinic. Conducting a clinical study is an exercise in logistics, and with a target of 3 clinical studies by early next year, those logistics considerable.
Those logistics can be broken into staffing, drug supply, appointment of clinical site, oversight of the study, and obtaining the required approvals.
For further information please download PDF attached:
Download this document
